Oct 04, 2021 / 12:30PM GMT
Operator
Good morning, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Conference Call. (Operator Instructions) Please be advised that today's call is being recorded.
I'd now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.
Eric Hyllengren - Atara Biotherapeutics, Inc. - VP of IR & Finance
Thank you, operator. Good morning, everyone. and welcome to Atara's Strategic Collaboration Conference Call. On today's call, members from the Atara executive team will discuss our recently announced strategic collaboration with Pierre Fabre. Earlier today, we issued a joint press release announcing that Atara and Pierre Fabre have entered into a strategic collaboration to commercialize tab-cel. This press release and a summary slide about the collaboration are available in the Investors and Media section at atarabio.com.
Joining me on today's call are: Dr. Pascal Touchon, President and Chief Executive Officer; Utpal Koppikar, Chief
Atara Biotherapeutics Inc and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel Corporate Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot